Publication | Open Access
The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5×FAD transgenic mice
16
Citations
10
References
2022
Year
Neurodegenerative DiseasesAlzheimer's DiseaseMedicineAptamer Ob2NeuropharmacologyDegenerative PathologyCognitive DeficitsNeuroprotectionNeuroscienceNovel Ache InhibitorPharmacologyProtective MechanismsNeuroinflammation
| Year | Citations | |
|---|---|---|
Page 1
Page 1